94508-9
SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Active
Term Description
Qualitative detection of IgM antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum, plasma or whole blood by rapid immunoassay methods. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Source: Regenstrief LOINC
Part Description
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
Reference Information
| Type | Source | Reference |
|---|---|---|
| Webcontent | Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. | Coronavirus (COVID-19) Testing |
Fully-Specified Name
- Component
- SARS coronavirus 2 Ab.IgM
- Property
- PrThr
- Time
- Pt
- System
- Ser/Plas/Bld
- Scale
- Ord
- Method
- IA.rapid
Additional Names
- Short Name
- SARS-CoV-2 IgM SerPlBld Ql IA.rapid
- Display Name
- SARS-CoV-2 (COVID-19) IgM IA.rapid Ql (S/P/Bld)
- Consumer Name Alpha Get Info
- SARS-CoV-2 (COVID-19) IgM antibody, Blood
Ask at Order Entry
81959-9 Public health laboratory ask at order entry panel
This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.
| LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
|---|---|---|---|---|
| 81959-9 | Public health laboratory ask at order entry panel | |||
| Indent81744-5 | Submitter's laboratory test method [Type] in Specimen | |||
| Indent81658-7 | Suspected organism [Identifier] in Specimen | |||
| Indent86952-9 | Preliminary testing done Specimen | |||
| Indent86953-7 | Preliminary testing result Specimen | |||
| Indent86955-2 | Preliminary testing affected submission for further testing Specimen | |||
| Indent95417-2 | Whether this is the patient's first test for condition of interest | |||
| Indent95418-0 | Whether patient is employed in a healthcare setting | |||
| Indent95419-8 | Whether the patient has symptoms related to condition of interest | |||
| Indent11368-8 | Illness or injury onset date and time | C | ||
| Indent77974-4 | Whether the patient was hospitalized for condition of interest | |||
| Indent95420-6 | Whether the patient was admitted to intensive care unit (ICU) for condition of interest | |||
| Indent95421-4 | Whether patient resides in a congregate care setting | |||
| Indent82810-3 | Pregnancy status | C | ||
| Indent30525-0 | Age | a |
Example Answer List: LL4623-6
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| PositiveCopyright http://snomed.info/sct ID:10828004 Positive (qualifier value) | LA6576-8 | ||
| NegativeCopyright http://snomed.info/sct ID:260385009 Negative (qualifier value) | LA6577-6 | ||
| Suspected | LA15291-0 | ||
| InvalidCopyright http://snomed.info/sct ID:455371000124106 Invalid result (qualifier value) | LA15841-2 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.69
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 94503-0 | SARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG51018-6 | SARSCoV2 antibody detection |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-AT | German (Austria) | Synonyms: SARS-CoV-2-AK IgM ql. |
| de-DE | German (Germany) | SARS-Coronavirus 2 Ak.IgM: |
| es-ES | Spanish (Spain) | Panel del SARS-CoV-2 (COVID-19) IgM: |
| es-MX | Spanish (Mexico) | SARS coronavirus 2 Ab.IgM: |
| fr-FR | French (France) | Coronavirus SARS-CoV-2 Ac IgM: |
| fr-CA | French (Canada) | coronavirus 2 du SRAS, IgM: |
| it-IT | Italian (Italy) | SARS coronavirus 2 Ab.IgM: Synonyms: Anticorpi IgM anticorpo Coronavirus della SARS Immunoassay Immunoassay rapido Microbiologia Plasma Plasma o Sangue Presenza o Soglia Punto nel tempo (episodio) Sangue SARS-CoV-2 (COVID-19) Siero Siero o Plasma Siero,Plasma o Sangue |
| nl-NL | Dutch (Netherlands) | SARS-CoV-2 As.IgM: Synonyms: antistof; |
| pl-PL | Polish (Poland) | SARS-CoV-2 Ab.IgM: Synonyms: IgM Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgM do SARS-CoV-2 (COVID-19) |
| zh-CN | Chinese (China) | SARS 冠状病毒 2 抗体.IgM: Synonyms: 2019 新型冠状病毒; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=94508-9
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright